ResearcherUniversity of Maryland, BaltimoreActive in the last 2 years

Audrey M. Lafargue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9551-2815; OpenAlex author ID A5062481690. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2026: 1 paper

Papers 1

Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo. Last author DOI 10.1038/s41684-026-01729-2 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

William L. Hwang · 1 shared paper, 2026 · strength 0.20
- Paper Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo. DOI 10.1038/s41684-026-01729-2 ↗
Phuoc Tho Tran · 1 shared paper, 2026 · strength 0.20
- Paper Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo. DOI 10.1038/s41684-026-01729-2 ↗
Muhammad Ajmal Khan · 1 shared paper, 2026 · strength 0.20
- Paper Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo. DOI 10.1038/s41684-026-01729-2 ↗
Ryan Jin-hyung Park · 1 shared paper, 2026 · strength 0.20
- Paper Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo. DOI 10.1038/s41684-026-01729-2 ↗
Jiayu Chen · 1 shared paper, 2026 · strength 0.20
- Paper Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo. DOI 10.1038/s41684-026-01729-2 ↗
Lei Zheng · 1 shared paper, 2026 · strength 0.20
- Paper Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo. DOI 10.1038/s41684-026-01729-2 ↗
Noelle R. J. Thielman · 1 shared paper, 2026 · strength 0.20
- Paper Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo. DOI 10.1038/s41684-026-01729-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.